The role of pancreatic polypeptide in the regulation of energy homeostasis

Molecular and Cellular Endocrinology

Volumn 418, Issue , 2015, Pages 33-41

  Khandekar, Neeta ^a   Berning, Britt A ^a   Sainsbury, Amanda ^b   Lin, Shu ^a,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Food intake; Neuronal pathway; Neuropeptide Y (NPY); Pancreatic polypeptide (PP)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED Y RECEPTOR; MELANOCORTIN; NEUROPEPTIDE Y; OBINEPITIDE; OREXIN; PANCREAS HORMONE; PANCREAS POLYPEPTIDE; PP 1420; UNCLASSIFIED DRUG; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y6 RECEPTOR;

ANOREXIA NERVOSA; ARTICLE; BRAIN STEM; BULIMIA; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; HORMONE RELEASE; HUMAN; HYPERPHAGIA; HYPOPHAGIA; HYPOTHALAMUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SATIETY; STOMACH EMPTYING; VAGUS NERVE; WEIGHT CONTROL; ANIMAL; EATING; ENERGY METABOLISM; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

ANIMALS; EATING; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; PANCREATIC POLYPEPTIDE; RECEPTORS, NEUROPEPTIDE Y;

EID: 84947042456     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.06.028     Document Type: Article

References (145)

1. Acuna-Goycolea C., Tamamaki N., et al. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 2005, 25(32):7406-7419.
2. Adrian T.E. Pancreatic polypeptide. J. Clin. Pathol. Suppl Assoc. Clin. Pathol. 1978, 8:43-50.
3. Adrian T.E., Besterman H.S., et al. Mechanism of pancreatic polypeptide release in man. Lancet 1977, 1(8004):161-163.
4. Adrian T.E., Bloom S.R., et al. Distribution and release of human pancreatic polypeptide. Gut 1976, 17(12):940-944.
5. Al Massadi O., Lear P.V., et al. Review of novel aspects of the regulation of ghrelin secretion. Curr. Drug Metab. 2014, 15(4):398-413.
6. Asakawa A., Inui A., et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003, 124(5):1325-1336.
7. Asnicar M.A., Koster A., et al. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 2002, 143(10):3994-4006.
8. Aton S.J., Herzog E.D. Come together, right...now: synchronization of rhythms in a mammalian circadian clock. Neuron 2005, 48(4):531-534.
9. Banerjee A., Onyuksel H. Human pancreatic polypeptide in a phospholipid-based micellar formulation. Pharm. Res. 2012, 29(6):1698-1711.
10. Barsh G., Gunn T., et al. Neuroendocrine regulation by the Agouti/Agrp-melanocortin system. Endocr. Res. 2000, 26(4):571.
11. Batterham R.L., Cowley M.A., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418(6898):650-654.
12. Batterham R.L., Heffron H., et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell. Metab. 2006, 4(3):223-233.
13. Batterham R.L., Le Roux C.W., et al. Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 2003, 88(8):3989-3992.
14. Bellmann-Sickert K., Elling C.E., et al. Long-acting lipidated analogue of human pancreatic polypeptide is slowly released into circulation. J. Med. Chem. 2011, 54(8):2658-2667.
15. Blomqvist A.G., Soderberg C., et al. Strong evolutionary conservation of neuropeptide Y: sequences of chicken, goldfish, and Torpedo marmorata DNA clones. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(6):2350-2354.
16. Bommer G., Friedl U., et al. Pancreatic PP cell distribution and hyperplasia. Immunocytochemical morphology in the normal human pancreas, in chronic pancreatitis and pancreatic carcinoma. Virchows Arch. A Pathol. Anat. Histol. 1980, 387(3):319-331.
17. Briggs D.I., Enriori P.J., et al. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 151(10):4745-4755.
18. Broberger C., Johansen J., et al. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(25):15043-15048.
19. Burkhoff A., Linemeyer D.L., et al. Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat. Brain Res. Mol. Brain Res. 1998, 53(1-2):311-316.
20. Cabrele C., Beck-Sickinger A.G. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J. Pept. Sci. 2000, 6(3):97-122.
21. Cabrele C., Wieland H.A., et al. Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides 2001, 22(3):365-378.
22. Castaneda T.R., Tong J., et al. Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocrinol. 2010, 31(1):44-60.
23. Catania A. The melanocortin system in leukocyte biology. J. Leukoc. Biol. 2007, 81(2):383-392.
24. Challis B.G., Pinnock S.B., et al. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem. Biophys. Res. Commun. 2003, 311(4):915-919.
25. Chandler-Laney P.C., Bush N.C., et al. Gut hormone activity of children born to women with and without gestational diabetes. Pediatr. Obes. 2014, 9(1):53-62.
26. Chaudhri O., Small C., et al. Gastrointestinal hormones regulating appetite. Philos. Trans. R. Soc. Lond B Biol. Sci. 2006, 361(1471):1187-1209.
27. Chronwall B.M. Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 1985, 6(Suppl. 2):1-11.
28. Chronwall B.M., DiMaggio D.A., et al. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 1985, 15(4):1159-1181.
29. Clark J.T., Kalra P.S., et al. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115(1):427-429.
30. Conlon J.M. The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP). Peptides 2002, 23(2):269-278.
31. Cummings D.E., Clement K., et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med. 2002, 8(7):643-644.
32. Cummings D.E., Overduin J. Gastrointestinal regulation of food intake. J. Clin. Invest 2007, 117(1):13-23.
33. Dakin C.L., Small C.J., et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004, 145(6):2687-2695.
34. Day J.W., Ottaway N., et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat. Chem. Biol. 2009, 5(10):749-757.
35. Dicken M.S., Tooker R.E., et al. Regulation of GABA and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks. J. Neurosci. 2012, 32(12):4042-4048.
36. Ekblad E., Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002, 23(2):251-261.
37. Elias C.F., Lee C., et al. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 1998, 21(6):1375-1385.
38. Feng H.S., Lynn R.B., et al. Gastric effects of TRH analogue and bicuculline injected into dorsal motor vagal nucleus in cats. Am. J. Physiol. 1990, 259(2 Pt 1):G321-G326.
39. Field B.C., Wren A.M., et al. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes 2010, 59(7):1635-1639.
40. Firozan B., Goudarzi I., et al. Estradiol increases expression of the brain-derived neurotrophic factor after acute administration of ethanol in the neonatal rat cerebellum. Eur. J. Pharmacol. 2014, 732:1-11.
41. Gantz I., Fong T.M. The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 2003, 284(3):E468-E474.
42. Gerald C., Walker M.W., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382(6587):168-171.
43. Germain N., Minnion J.S., et al. Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active. Peptides 2013, 39:6-10.
44. Gregor P., Millham M.L., et al. Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEBS Lett. 1996, 381(1-2):58-62.
45. Gustafson E.L., Smith K.E., et al. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Brain Res. Mol. Brain Res. 1997, 46(1-2):223-235.
46. Gutzwiller J.P., Goke B., et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999, 44(1):81-86.
47. Guyenet S.J., Schwartz M.W. Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J. Clin. Endocrinol. Metab. 2012, 97(3):745-755.
48. Hahn T.M., Breininger J.F., et al. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1998, 1(4):271-272.
49. Hankir M.K., Parkinson J.R., et al. Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging. J. Neuroendocrinol. 2011, 23(4):371-380.
50. Hannibal J., Hsiung H.M., et al. Temporal phasing of locomotor activity, heart rate rhythmicity, and core body temperature is disrupted in VIP receptor 2-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300(3):R519-R530.
51. Harmar A.J., Marston H.M., et al. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 2002, 109(4):497-508.
52. Haynes A.C., Jackson B., et al. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999, 20(9):1099-1105.
53. He L., Gunn T.M., et al. A biochemical function for attractin in agouti-induced pigmentation and obesity. Nat. Genet. 2001, 27(1):40-47.
54. Heijboer A.C., Pijl H., et al. Gut-brain axis: regulation of glucose metabolism. J. Neuroendocrinol. 2006, 18(12):883-894.
55. Hellstrom P.M., Gryback P., et al. The physiology of gastric emptying. Best. Pract. Res. Clin. Anaesthesiol. 2006, 20(3):397-407.
56. Holzer P., Reichmann F., et al. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides 2012, 46(6):261-274.
57. Huang W., Ramsey K.M., et al. Circadian rhythms, sleep, and metabolism. J. Clin. Invest 2011, 121(6):2133-2141.
58. Huszar D., Lynch C.A., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88(1):131-141.
59. Inui A., Asakawa A., et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 2004, 18(3):439-456.
60. Inui A., Okita M., et al. Neuropeptide regulation of feeding in dogs. Am. J. Physiol. 1991, 261(3 Pt 2):R588-R594.
61. Jegou S., Tranchand-Bunel D., et al. Characterization of alpha-MSH-related peptides released from rat hypothalamic neurons in vitro. Brain Res. Mol. Brain Res. 1989, 5(3):219-226.
62. Jesudason D.R., Monteiro M.P., et al. Low-dose pancreatic polypeptide inhibits food intake in man. Br. J. Nutr. 2007, 97(3):426-429.
63. Kanaley J.A., Heden T.D., et al. Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals. Int. J. Obes. (Lond) 2014, 38(2):266-271.
64. Kanatani A., Mashiko S., et al. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 2000, 141(3):1011-1016.
65. Katsuura G., Asakawa A., et al. Roles of pancreatic polypeptide in regulation of food intake. Peptides 2002, 23(2):323-329.
66. Keire D.A., Mannon P., et al. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279(1):G126-G131.
67. Kimmel J.R., Hayden L.J., et al. Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 1975, 250(24):9369-9376.
68. King B.M. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol. Behav. 2006, 87(2):221-244.
69. Kinzig K.P., Coughlin J.W., et al. Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration. Am. J. Physiol. Endocrinol. Metab. 2007, 292(5):E1441-E1446.
70. Kohno D., Yada T. Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Neuropeptides 2012, 46(6):315-319.
71. Kojima S., Ueno N., et al. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 2007, 28(2):459-463.
72. Komori T., Morikawa Y., et al. Induction of brain-derived neurotrophic factor by leptin in the ventromedial hypothalamus. Neuroscience 2006, 139(3):1107-1115.
73. Komori T., Morikawa Y., et al. Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob/ob mice under basal conditions. Brain Res. 2005, 1049(1):34-42.
74. Kristensen P., Judge M.E., et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998, 393(6680):72-76.
75. Larsen P.J., Kristensen P. The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex. Brain Res. Mol. Brain Res. 1997, 48(1):1-6.
76. Larsson L.I., Sundler F., et al. Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell. Tissue Res. 1975, 156(2):167-171.
77. le Roux C.W., Batterham R.L., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147(1):3-8.
78. Lebrun B., Bariohay B., et al. Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton. Neurosci. 2006, 126-127:30-38.
79. Lieverse R.J., Jansen J.B., et al. Satiety effects of a physiological dose of cholecystokinin in humans. Gut 1995, 36(2):176-179.
80. Lin S., Shi Y.C., et al. Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. PLoS One 2009, 4(12):e8488.
81. Little T.J., Horowitz M., et al. Role of cholecystokinin in appetite control and body weight regulation. Obes. Rev. 2005, 6(4):297-306.
82. Liu Y.L., Semjonous N.M., et al. The effects of pancreatic polypeptide on locomotor activity and food intake in mice. Int. J. Obes. (Lond) 2008, 32(11):1712-1715.
83. Lumb K.J., DeCarr L.B., et al. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice. J. Med. Chem. 2007, 50(9):2264-2268.
84. Luo N., Marcelin G., et al. Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency. Endocrinology 2011, 152(3):883-889.
85. MacIntosh C.G., Horowitz M., et al. Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men. Am. J. Gastroenterol. 2001, 96(4):997-1007.
86. Malaisse-Lagae F., Carpentier J.L., et al. Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia 1977, 33(7):915-917.
87. Marco J., Zulueta M.A., et al. Reduced pancreatic polypeptide secretion in obese subjects. J. Clin. Endocrinol. Metab. 1980, 50(4):744-747.
88. Mashiko S., Moriya R., et al. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. Eur. J. Pharmacol. 2009, 615(1-3):113-117.
89. Matsumoto M., Nomura T., et al. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 1996, 271(44):27217-27220.
90. McLaughlin C.L., Baile C.A. Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide. Physiol. Behav. 1981, 26(3):433-437.
91. McTigue D.M., Hermann G.E., et al. Effect of pancreatic polypeptide on rat dorsal vagal complex neurons. J. Physiol. 1997, 499(Pt 2):475-483.
92. Mercer R.E., Chee M.J., et al. The role of NPY in hypothalamic mediated food intake. Front. Neuroendocrinol. 2011, 32(4):398-415.
93. Mountjoy K.G., Robbins L.S., et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257(5074):1248-1251.
94. Naessen S., Carlstrom K., et al. Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal. Am. J. Clin. Nutr. 2011, 94(4):967-972.
95. Nakagawa T., Tsuchida A., et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000, 49(3):436-444.
96. Nakajima M., Inui A., et al. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J. Pharmacol. Exp. Ther. 1994, 268(2):1010-1014.
97. Naslund E., Barkeling B., et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. Relat. Metab. Disord. 1999, 23(3):304-311.
98. Ng M., Fleming T., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global Burden of disease study 2013. Lancet 2014, 384(9945):766-781.
99. Niewiadomski P., Coute-Monvoisin A.C., et al. Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death. J. Mol. Neurosci. 2008, 36(1-3):200-207.
100. Nonomura T., Tsuchida A., et al. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int. J. Exp. Diabetes Res. 2001, 2(3):201-209.
101. Ono M., Ichihara J., et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem. Biophys. Res. Commun. 1997, 238(2):633-637.
102. Orci L., Baetens D., et al. Pancreatic polypeptide and glucagon : non-random distribution in pancreatic islets. Life Sci. 1976, 19(12):1811-1815.
103. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 1999, 11(4):1431-1448.
104. Patel V., Joharapurkar A., et al. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice. Can. J. Physiol. Pharmacol. 2013, 91(12):1009-1015.
105. Perry B., Wang Y. Appetite regulation and weight control: the role of gut hormones. Nutr. Diabetes 2012, 2:e26.
106. Pyarokhil A.H., Ishihara M., et al. Immunohistochemical study on the ontogenetic development of the regional distribution of peptide YY, pancreatic polypeptide, and glucagon-like peptide 1 endocrine cells in bovine gastrointestinal tract. Regul. Pept. 2012, 175(1-3):15-20.
107. Rahier J., Wallon J., et al. Localization of pancreatic polypeptide cells in a limited lobe of the human neonate pancreas: remnant of the ventral primordium?. Cell. Tissue Res. 1979, 200(3):359-366.
108. Reinehr T., Enriori P.J., et al. Pancreatic polypeptide in obese children before and after weight loss. Int. J. Obes. (Lond) 2006, 30(10):1476-1481.
109. Rogers R.C., Hermann G.E., et al. Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat. J. Physiol. 1999, 514(Pt 2):369-383.
110. Rogers R.C., McTigue D.M., et al. Vagal control of digestion: modulation by central neural and peripheral endocrine factors. Neurosci. Biobehav Rev. 1996, 20(1):57-66.
111. Rose P.M., Lynch J.S., et al. Molecular genetic analysis of a human neuropeptide Y receptor. The human homolog of the murine "Y5" receptor may be a pseudogene. J. Biol. Chem. 1997, 272(6):3622-3627.
112. Sainsbury A., Shi Y.C., et al. Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways. Neuropeptides 2010, 44(3):261-268.
113. Sakata I., Sakai T. Ghrelin cells in the gastrointestinal tract. Int J Pept 2010, 2010.
114. Sakurai T., Amemiya A., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(5). 1 page following 696.
115. Schmidt J.B., Gregersen N.T., et al. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men. Am. J. Physiol. Endocrinol. Metab. 2014, 306(11):E1248-E1256.
116. Schmidt P.T., Naslund E., et al. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control. J. Clin. Endocrinol. Metab. 2005, 90(9):5241-5246.
117. Schwartz G.J. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 2000, 16(10):866-873.
118. Schwartz G.J., Salorio C.F., et al. Gut vagal afferent lesions increase meal size but do not block gastric preload-induced feeding suppression. Am. J. Physiol. 1999, 276(6 Pt 2):R1623-R1629.
119. Schwartz M.W., Porte D. Diabetes, obesity, and the brain. Science 2005, 307(5708):375-379.
120. Schwartz T.W. Pancreatic polypeptide: a unique model for vagal control of endocrine systems. J. Auton. Nerv. Syst. 1983, 9(1):99-111.
121. Schwartz T.W., Holst J.J., et al. Vagal, cholinergic regulation of pancreatic polypeptide secretion. J. Clin. Invest 1978, 61(3):781-789.
122. Shi Y.C., Lin Z., et al. PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice. Obes. (Silver Spring) 2013, 21(12):E669-E678.
123. Shutter J.R., Graham M., et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes. Dev. 1997, 11(5):593-602.
124. Simonian H.P., Kresge K.M., et al. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol. Motil. 2005, 17(3):348-354.
125. Sturm K., Parker B., et al. Energy intake and appetite are related to antral area in healthy young and older subjects. Am. J. Clin. Nutr. 2004, 80(3):656-667.
126. Tan T.M., Field B.C., et al. Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420. Br. J. Clin. Pharmacol. 2012, 73(2):232-239.
127. Tasan R.O., Lin S., et al. Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 2009, 158(4):1717-1730.
128. Tauber M., Diene G., et al. Prader-Willi syndrome as a model of human hyperphagia. Front. Horm. Res. 2014, 42:93-106.
129. Taylor I.L., Garcia R. Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice. Am. J. Physiol. 1985, 248(3 Pt 1):G277-G280.
130. Ter Horst G.J., de Boer P., et al. Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience 1989, 31(3):785-797.
131. Ter Horst G.J., Luiten P.G., et al. Descending pathways from hypothalamus to dorsal motor vagus and ambiguus nuclei in the rat. J. Auton. Nerv. Syst. 1984, 11(1):59-75.
132. Troke R.C., Tan T.M., et al. The future role of gut hormones in the treatment of obesity. Ther. Adv. Chronic Dis. 2014, 5(1):4-14.
133. Ueno N., Inui A., et al. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999, 117(6):1427-1432.
134. Valenzuela J.E., Defilippi C. Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat. Gastroenterology 1981, 81(5):898-902.
135. Vergoni A.V., Bertolini A. Role of melanocortins in the central control of feeding. Eur. J. Pharmacol. 2000, 405(1-3):25-32.
136. Verschueren S., Janssen P., et al. Effect of pancreatic polypeptide on gastric accommodation and gastric emptying in conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 307(1):G122-G128.
137. Wang G.J., Tomasi D., et al. Gastric distention activates satiety circuitry in the human brain. Neuroimage 2008, 39(4):1824-1831.
138. Wang J., Yuan Z., et al. Neuropeptide Y loses its orexigenic effect in rats with lesions of the hypothalamic paraventricular nucleus. Endocr. Res. 2013, 38(1):8-14.
139. Wynne K., Park A.J., et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes 2005, 54(8):2390-2395.
140. Xu B., Goulding E.H., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 2003, 6(7):736-742.
141. Xu X., Zhu H., et al. Pyloric electrical stimulation reduces food intake by inhibiting gastric motility in dogs. Gastroenterology 2005, 128(1):43-50.
142. Yulyaningsih E., Loh K., et al. Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice. Cell. Metab. 2014, 19(1):58-72.
143. Zac-Varghese S., De Silva A., et al. Translational studies on PYY as a novel target in obesity. Curr. Opin. Pharmacol. 2011, 11(6):582-585.
144. Zheng F., Kim Y.J., et al. Overexpression of neuropeptide Y in the dorsomedial hypothalamus causes hyperphagia and obesity in rats. Obes. (Silver Spring) 2013, 21(6):1086-1092.
145. Zipf W.B., O'Dorisio T.M., et al. Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 1981, 52(6):1264-1266.